During the past decade, Nephrologisches Zentrum Mettmann conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nephrologisches Zentrum Mettmann" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator and "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Nephrologisches Zentrum Mettmann" are "Chronic Kidney Disease" (2 trials). Many other conditions were trialed in "Nephrologisches Zentrum Mettmann" in a lesser frequency.

Most popular intervention types in "Nephrologisches Zentrum Mettmann" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (1 trials), "HX575 recombinant human erythropoietin alfa" (1 trials) and "Matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nephrologisches Zentrum Mettmann" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Nephrologisches Zentrum Mettmann". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Nephrologisches Zentrum Mettmann, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nephrologisches Zentrum Mettmann, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".